Fund HoldingsCheckpoint Capital L.P.

Total Portfolio Value
$196.48M
Total Bought
$49.97M
Total Sold
$44.34M
Net Transaction
+$5.63M
Filing Period:
Securities
SharesValue ($K)
Q3 2024
Q4 2024
Change
Q3 2024
Q4 2024
Weight (%)
Change
DISC MEDICINE INC(IRON)25,543185,000+159,4571,25511,7295.97%+10,474
REVOLUTION MEDICINES INC(RVMD)0210,000+210,00009,1854.67%+9,185
ARGENX SE(ARGX)92,50092,500050,14256,88828.95%+6,745
RHYTHM PHARMACEUTICALS INC(RYTM)663,381727,982+64,60134,75540,75220.74%+5,998
TREVI THERAPEUTICS INC(TRVI)250,0001,084,135+834,1358354,4672.27%+3,632
CIDARA THERAPEUTICS INC182,426196,949+14,5231,9615,1142.60%+3,153
KYMERA THERAPEUTICS INC(KYMR)077,535+77,53503,1191.59%+3,119
PLIANT THERAPEUTICS INC380,000535,494+155,4944,2607,0523.59%+2,793
STOKE THERAPEUTICS INC(STOK)157,514305,387+147,8731,9363,3681.71%+1,433
TSCAN THERAPEUTICS INC825,3411,755,987+930,6464,1105,3382.72%+1,228
SOLENO THERAPEUTICS INC57,98370,027+12,0442,9283,1481.60%+220
ALLAKOS INC649,9570-649,9574250-425
ATYR PHARMA INC1,736,477432,561-1,303,9163,0561,5660.80%-1,490
AVADEL PHARMACEUTICALS PLC1,100,0001,004,790-95,21014,42710,5605.37%-3,866
AXSOME THERAPEUTICS INC(AXSM)209,632174,769-34,86318,84014,7877.53%-4,052
PHATHOM PHARMACEUTICALS INC(PHAT)1,504,3072,274,157+769,85027,19818,4669.40%-8,732
PROTAGONIST THERAPEUTICS INC240,0000-240,00010,8000-10,800
CYTOKINETICS INC(CYTK)466,81320,000-446,81324,6489410.48%-23,707
Page 1 of 1